[HTML][HTML] Efficacy and safety of NVX-CoV2373 in adults in the United States and Mexico
…, RS McClelland, V Garcia-Fragoso… - … England Journal of …, 2022 - Mass Medical Soc
Background NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (…
Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico (preprint)
…, DF Florescu, S McClelland, V Garcia-Fragoso… - 2021 - pesquisa.bvsalud.org
BACKGROUND Vaccination using severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
spike (S) protein antigen has been effective in the prevention of coronavirus disease …
spike (S) protein antigen has been effective in the prevention of coronavirus disease …
Loss of parental role as a cause of stress in the neonatal intensive care unit.
…, N Claudio, V Ramirez, L Garcia-Fragoso - Boletin de la …, 2012 - europepmc.org
Results Most of the parents (46%) rated the experience to be extremely stressful. The principal
cause of stress was the alteration in parental role and being separated from their baby. …
cause of stress was the alteration in parental role and being separated from their baby. …
A novel antigenic site spanning domains I and III of the Zika virus envelope glycoprotein is the target of strongly neutralizing human monoclonal antibodies
SD Graham, HA Tu, BD McElvany, NR Graham… - Journal of …, 2021 - Am Soc Microbiol
Zika virus (ZIKV), a mosquito-transmitted flavivirus, caused a large epidemic in Latin America
between 2015 and 2017. Effective ZIKV vaccines and treatments are urgently needed to …
between 2015 and 2017. Effective ZIKV vaccines and treatments are urgently needed to …
[HTML][HTML] Developmental Biology in Central America, the northern region of South America and the Caribbean
JE García-Arrarás - The International journal of developmental …, 2021 - ncbi.nlm.nih.gov
This review highlights the history of Developmental Biology studies in Latin-American countries
of Central America, the northern region of South America and the Caribbean and their …
of Central America, the northern region of South America and the Caribbean and their …
Impact of time interval between primary Dengue infection and subsequent Zika exposure in Zika pathogenesis using a non-human primate model
C Serrano - 2020 - search.proquest.com
Dengue is arguably the most medically important arboviral disease. It’s endemic in at least
100 countries throughout the world, including Puerto Rico, imposing a large public health …
100 countries throughout the world, including Puerto Rico, imposing a large public health …
[HTML][HTML] Favipiravir Suppresses Zika Virus (ZIKV) through Activity as a Mutagen
In a companion paper, we demonstrated that the nucleoside analogue favipiravir (FAV)
suppressed Zika virus (ZIKV) replication in three human-derived cell lines—HeLa, SK-N-MC, and …
suppressed Zika virus (ZIKV) replication in three human-derived cell lines—HeLa, SK-N-MC, and …
[HTML][HTML] Review 1:" Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico"
G Tan - Rapid Reviews Infectious Diseases, 2022 - rapidreviewscovid19.mitpress.mit …
AbstractBACKGROUNDVaccination using severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) spike (S) protein antigen has been effective in the prevention of coronavirus …
(SARS-CoV-2) spike (S) protein antigen has been effective in the prevention of coronavirus …
[PDF][PDF] Ilka C. Ríos Reyes, DMD, MS
MIC Laboy - 2013 - prhsj.rcm.upr.edu
M. Silverman‡.* University of Puerto Rico Medical Sciences Campus, San Juan, Puerto Rico;†
Private Practice;‡ Mount Sinai School of Medicine, New York, New York, United States of …
Private Practice;‡ Mount Sinai School of Medicine, New York, New York, United States of …
Application of traditional vaccine development strategies to SARS-CoV-2
Over the past 150 years, vaccines have revolutionized the relationship between people and
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …
disease. During the COVID-19 pandemic, technologies such as mRNA vaccines have …
